Sort
82,697 grants matching “vaccine development”
Global innate immune responses to HIV-1 infection
$4,254,392John A T Young · Salk Institute For Biological Studies · P01 · FY2010 · AI
Development of rationally designed HIV vaccines
$4,253,554Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Biodefense/Emerging Infection Vaccine Studies
$4,251,944Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Biodefense/Emerging Infection Vaccine Studies
$4,251,944Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Region VI Center for Biodefence and Emerging Infections
$4,242,615University Of Texas Medical Br Galveston · U54 · FY2003 · AI
Design and evaluation of pan-CoV vaccines
$4,242,156Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2021 · AI
Infectious Diseases Fellowship Program
$4,239,245Christa Zerbe · National Institute Of Allergy And Infectious Diseases · ZIE · FY2025 · AI
Endotypes: Mechanisms and Consequences for Airway Epithelium and Mucus
$4,237,614David J Erle · University Of California, San Francisco · U19 · FY2020 · AI
HPV TYPE 16 VACCINE TRIAL IN COSTA RICA
$4,236,717Rolando Herrero · Fundacion Inciensa · N01 · FY2011 · CA
Development of a COVID-19 Vaccine
$4,236,540Steven Reed · Hdt Bio Corporation · N01 · FY2020 · AI
Comprehensive Characterization of the T-cell Response to KSHV to Enable Specific Immune Therapy
$4,234,248Edus Houston Warren · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Development of rationally designed HIV vaccines
$4,231,061Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Southern California Primary Infection Program
$4,225,560University Of California San Diego · U01 · FY2005 · AI
Influenza and Emerging Infectious Diseases
$4,224,059Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Project 2: PanbetaCoV protein vaccine design
$4,217,384Kevin Wiehe · Duke University · P01 · FY2021 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$4,216,430Judith S. Currier · University Of California Los Angeles · UM1 · FY2012 · AI
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine
$4,212,877Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine
$4,212,877Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$4,212,644Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2011 · RR
Rationally designed targeted immunogens to elicit HIV Envelope V2-apex broadly neutralizing antibodies
$4,211,839Raiees Ahmad Andrabi · University Of Pennsylvania · U19 · FY2025 · AI
Clinical Trials of Biodefense Vaccines (Dengue)
$4,211,550Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
The University of North Carolina Center for AIDS Research
$4,209,183Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2021 · AI
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$4,208,801Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
SERCEB Southeast Regional Centers of Excellence for Bio*
$4,207,052Duke University · U54 · FY2003 · AI
Development of rationally designed HIV vaccines
$4,206,398Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA